tiprankstipranks
Advertisement
Advertisement

Splash Beverage Announces Planned Merger With Medterra CBD

Story Highlights
  • Splash Beverage signed a March 4, 2026 LOI to merge with Medterra CBD, valuing Medterra at $37.6 million in equity.
  • The proposed merger hinges on financing, due diligence and shareholder approval, and would reshape Splash’s capital structure and leadership.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Splash Beverage Announces Planned Merger With Medterra CBD

Claim 30% Off TipRanks

Splash Beverage Group ( (SBEV) ) has shared an announcement.

On March 4, 2026, Splash Beverage Group entered into a letter of intent with Medterra CBD for a potential merger valuing Medterra at $37.6 million, to be paid in approximately 75.2 million shares assuming repayment of its $10.4 million debt. The deal structure involves issuing up to 19.99% of Splash’s outstanding common stock at closing, with the balance in new Series X and Series X-1 preferred shares convertible at $0.50 per share, subject to downside price protection, NYSE American floor rules and redemption features tied to future securities offerings.

Completion of the transaction remains contingent on due diligence, a definitive merger agreement, audited Medterra financials, shareholder approval and Splash raising capital to retire Medterra’s debt, with a $250,000 liquidated damages clause if Splash does not use commercially reasonable efforts to secure approval within specified deadlines. The letter also anticipates Medterra management joining Splash’s leadership and requires Medterra to be delivered with normalized net working capital, signaling a bid to strengthen Splash’s balance sheet, expand into cannabinoid wellness and reshape its governance and capital structure if the merger closes.

The most recent analyst rating on (SBEV) stock is a Hold with a $0.66 price target. To see the full list of analyst forecasts on Splash Beverage Group stock, see the SBEV Stock Forecast page.

Spark’s Take on SBEV Stock

According to Spark, TipRanks’ AI Analyst, SBEV is a Neutral.

The score is held down primarily by very weak financial performance (sharp TTM revenue contraction, negative gross profit, large losses, and ongoing cash burn). Technicals also remain unfavorable with the stock below longer-term moving averages and a negative MACD. Valuation is constrained by losses and no dividend, while the recent positive distribution/branding event offers some upside but is not large enough to offset the core financial and trend risks.

To see Spark’s full report on SBEV stock, click here.

More about Splash Beverage Group

Splash Beverage Group, Inc. operates in the beverage sector with a focus on branded drinks, and the company is listed on the NYSE American exchange. Medterra CBD, LLC, its proposed merger partner, is a leading manufacturer and multi-brand operator of federally compliant cannabinoid wellness products, positioning the combined entity to participate in the growing cannabinoid-based wellness and beverage markets.

Average Trading Volume: 1,019,674

Technical Sentiment Signal: Sell

Current Market Cap: $1.65M

For detailed information about SBEV stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1